<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT2013073114238N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2013-12-20</date_registration>
      <primary_sponsor>Dr.Erfan Sedaghat</primary_sponsor>
      <public_title>Evaluation of the effect of acupuncture in reducing intraoperative bleeding in rhinoplasty.</public_title>
      <acronym></acronym>
      <scientific_title>Comparative effects of acupuncture and placebo acupuncture in reducing intraoperative bleeding in open rhinoplasty surgery in patients 18 to 45 years, ASA class1 in Vali Asr Operation Room, Imam Khomeini Hospital 1390-91 years, a randomized clinical trial.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2012-05-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>88</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/13877</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention, Other design features: This innovation was first used in the world, Randomization description: computer-generated random number, Blinding description: The acupuncture points and needles were covered by drapes in both groups for 30 minutes to make other members of the team blind to the group assignment of patients. Another anesthesiologist, who was blinded to the treatment group allocation, collected the data during the operations.</study_design>
      <phase>N/A</phase>
      <hc_freetext>intra operative bleeding.</hc_freetext>
      <i_freetext>Intervention 1: In all three groups of Method of anesthesia is General Anesthesia  and endotracheal intubation .after prepare and Preoxygenation premedication drug  Midazolam 0.015 -0.05   mg / kg and opioid (usually Fentanyl (1-2mcg/kg administration and then Intravenous anesthetic Propofol  2 mg / kg  and muscle relaxants (Atracurium 0.5-0.6 mg / kg) is administered and intubation with Appropriately sized endotracheal tube is performed.maintanance of anesthesia for all patients, in addition to a percentage of Isoflurane gas inhalation  infusion of Ringer ml 1000, induced hypotension with Remifentanil infusion syringe pump at a dose of 0.5 mcg / kg / min and Propofol 50mcg/kg/min. oxygen and nitrous oxide 50:50 with  and Atracurium 10 mg   will be given 30 minutes to complete anesthesia. Applied to all patients 1 to 2 mL of 1% lidocaine solution impregnated Adrenaline 1 in 200,000 in the lateral wall nose before surgery by the surgeon will inject.Group I: Patients with induced hypotension to control bleeding only  routine infusion (propofol and remifentanil) are used to them. (Contro group). Intervention 2: in case group:&#13;
. For medical treatment Acupuncture in point of LIV-3, SP-1, ST-45, BL-67 with special Disposable Needle Acupuncture  CE0197 and FDA certification mark licensed HUANQIU No. 25 will 510K.011242 numbers. Looking for&#13;
This points out the PRO900 ACUHEALTH TENS device CE0120 certificate and FDA approval of Australia&#13;
Will be used. Intervention 3: Blinding of the surgeon in order to make acupuncture channel points out that By Acuhealth have been identified as areas outside of the channel by the same faculty member with a needle anesthesia Are stimulated.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr.Shahram Samadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Imam Khomeini Hospital,end of Keshavarz bolvar</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>149733141</zip>
        <telephone>+98 21 6658 1576</telephone>
        <email>shsamadi@yahoo.com</email>
        <affiliation>Imam Hospital</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr.Shahram Samadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Imam Khomeini Hospital, end of Keshavarz Bolvar</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>149733141</zip>
        <telephone>+98 21 6658 1576</telephone>
        <email>shsamadi@yahoo.com</email>
        <affiliation>Imam Khomeini Hospital complex</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>candidates for primary open rhinoplasty</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>45 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>recent treatment with acupuncture,
revision surgery,
cardiovascular disease (congestive heart failure, coronary artery disease)
, cerebrovascular disease,
poorly controlled arterial hypertension,
history of renal or hepatic insufficiency,
history of drug abuse,
the presence of a pacemaker,
coagulation disorders,
neurological disorders,
pregnancy
patients taking corticosteroid.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>Z40-Z54</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Persons encountering health services for specific procedures and health care</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>In all three groups of Method of anesthesia is General Anesthesia  and endotracheal intubation .after prepare and Preoxygenation premedication drug  Midazolam 0.015 -0.05   mg / kg and opioid (usually Fentanyl (1-2mcg/kg administration and then Intravenous anesthetic Propofol  2 mg / kg  and muscle relaxants (Atracurium 0.5-0.6 mg / kg) is administered and intubation with Appropriately sized endotracheal tube is performed.maintanance of anesthesia for all patients, in addition to a percentage of Isoflurane gas inhalation  infusion of Ringer ml 1000, induced hypotension with Remifentanil infusion syringe pump at a dose of 0.5 mcg / kg / min and Propofol 50mcg/kg/min. oxygen and nitrous oxide 50:50 with  and Atracurium 10 mg   will be given 30 minutes to complete anesthesia. Applied to all patients 1 to 2 mL of 1% lidocaine solution impregnated Adrenaline 1 in 200,000 in the lateral wall nose before surgery by the surgeon will inject.Group I: Patients with induced hypotension to control bleeding only  routine infusion (propofol and remifentanil) are used to them. (Contro group)</i_keyword>
      <i_keyword>in case group:&#13;
. For medical treatment Acupuncture in point of LIV-3, SP-1, ST-45, BL-67 with special Disposable Needle Acupuncture  CE0197 and FDA certification mark licensed HUANQIU No. 25 will 510K.011242 numbers. Looking for&#13;
This points out the PRO900 ACUHEALTH TENS device CE0120 certificate and FDA approval of Australia&#13;
Will be used.</i_keyword>
      <i_keyword>Blinding of the surgeon in order to make acupuncture channel points out that By Acuhealth have been identified as areas outside of the channel by the same faculty member with a needle anesthesia Are stimulated.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Intra operative bleeding. Timepoint: Immediately after intervention. Method of measurement: gauze surgical weight with a digital scale and measuring goats milligrams per milliliter of blood volume in the suction and  hemoglobin levels before and after surgery and surgeon satisfaction questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Reduced mean artrial blood presure. Timepoint: After intervention and during surgery. Method of measurement: Monitoring the pressure gauge on mmHg.</sec_outcome>
      <sec_outcome>Improve richmond criteria in Recovery. Timepoint: after surgery and entering the patient to recovery. Method of measurement: Questionnaire Form.</sec_outcome>
      <sec_outcome>Improved patient satisfaction who have congestive problems. Timepoint: when the patient  leaving recovery. Method of measurement: Questionnaire Form.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Dr.Erfan Sedaghat</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2013-11-30</approval_date>
        <contact_name>Tehran Univercity of Medical Science</contact_name>
        <contact_address>Central Department of Tehran univercity, 6th floor, Ghods avenue, Keshavarz Bolvar Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
